Updated on 10 July 2013
Exhibitors’ stall at 7th in-Pharma Japan and 26th Interphex Japan, which are being held from July 10 to 12, 2013, at Tokyo Big Sight, Japan
Tokyo: The 7th in-Pharma Japan and 26th Interphex Japan, which are being concurrently held at Tokyo Big Sight, Japan, kick started with much pomp and grandeur. The keynote address, which featured the theme, ‘Quest for Growth', emphasized on how life science firms in Japan are venturing into emerging markets in China, India, Brazil and Russia (BRIC), among other nations, despite stifled innovation in the ‘land of the rising sun'.
The keynote was delivered by Dr Taro Iwamoto, president and representative director, Otsuka Pharmaceutical, Japan; Mr Tony Alvarez, representative director and president, MSD (Merck Sharpe Dohme) KK, and Mr Fumiyoshi Sakai, director, equity research, equities, Credit Suisse Securities, Japan. All three speakers concurred on the observation that in today's world, growth and innovation go hand in hand.
The success formula
Dr Iwamoto said that in order to innovate and to grow, a company should create business leaders, who have experience and can deal with the diverse aspects of business in diverse regions of the world. Dr Iwamoto, who formerly faced a tough time working with US firm Syntex due to his English language barrier, said that he follows the success mantra put forward by best selling author Mr Jack Welsh - be full of energy, energize the team mates, be on the edge all times in terms of idea generation, execute protocols, and work with passion.
He further added that leaders should not only 'act' on protocols but also 'produce' the best methodologies. He said that the best way to innovate is to change oneself and create something new. "Innovation is not development of technology, it is what you can develop in order to meet the demands of your customer," said Dr Iwamoto.